Reducing salt intake for prevention of cardiovascular diseases in high-risk patients by advanced health education intervention (RESIP-CVD study), Northern Thailand: Study protocol for a cluster randomized trial

Trials

Volumn 13, Issue , 2012, Pages

  Aung, Myo N ^a,b   Yuasa, Motoyuki ^a   Moolphate, Saiyud ^c   Nedsuwan, Supalert ^d   Yokokawa, Hidehiro ^a   Kitajima, Tsutomu ^e   Minematsu, Kazuo ^a   Tanimura, Susumu ^f   Fukuda, Hiroshi ^a   Hiratsuka, Yoshimune ^g   Ono, Koichi ^a   Kawai, Sachio ^h   Marui, Eiji ^a  

^a JUNTENDO UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^b Boromrajonani College of Nursing Nakhon Lampang (BCNLP)   (Thailand)

^c TB/HIV Research Project   (Thailand)

^d Chiang Rai Regional Hospital   (Thailand)

^e KYORIN UNIVERSITY   (Japan)

^f HYOGO COLLEGE OF MEDICINE   (Japan)

^g NATIONAL INSTITUTE OF PUBLIC HEALTH   (Japan)

^h JUNTENDO UNIVERSITY   (Japan)

Author keywords

Behavior; CVD; Intervention; Salt; Thailand

Indexed keywords

ADULT; ARTICLE; BLOOD PRESSURE REGULATION; CARDIOVASCULAR DISEASE; CARDIOVASCULAR MORTALITY; CONTROLLED STUDY; FOLLOW UP; HEALTH EDUCATION; HIGH RISK PATIENT; HUMAN; INCIDENCE; INTERVENTION STUDY; MAJOR CLINICAL STUDY; MORBIDITY; RANDOMIZED CONTROLLED TRIAL (TOPIC); SALT INTAKE; THAILAND;

CARDIOVASCULAR DISEASES; CLINICAL PROTOCOLS; HEALTH EDUCATION; HUMANS; RISK; SAMPLE SIZE; SODIUM CHLORIDE, DIETARY; THAILAND;

EID: 84865635909     PISSN: None     EISSN: 17456215     Source Type: Journal    
DOI: 10.1186/1745-6215-13-158     Document Type: Article

References (38)

1. Cardiovascular diseases Key messages to protect heart health http://www.who.int/cardiovascular_diseases/en/, Cardiovascular diseases.
2. Beaglehole R, Bonita R, Horton R, Adams C, Alleyne G, Asaria P, Baugh V, Bekedam H, Billo N, Casswell S, et al. Priority actions for the non-communicable disease crisis. Lancet 2011, 377:1438-1447. 10.1016/S0140-6736(11)60393-0, 21474174.
3. Bureau of Health Policy and Strategy, Ministry of Public Health Thailand Number of Deaths and Death Rates per 100,000 Population by Leading Causes of Death 2005-2009, http://bps.ops.moph.go.th/Statistic/2.3.4-52.pdf, Bureau of Health Policy and Strategy, Ministry of Public Health Thailand.
4. Bureau of Health Policy and Strategy, Ministry of Public Health Thailand The top ten causes of morbidity rate per 100,000 population in the inpatients 2009, http://bps.ops.moph.go.th/Ill/%E0%B8%9B%E0%B9%88%E0%B8%A7%E0%B8%A252/10%20%E0%B8%A5%E0%B8%B3%E0%B8%94%E0%B8%B1%E0%B8%9A%E0%B8%9C%E0%B8%B9%E0%B9%89%E0%B8%9B%E0%B9%88%E0%B8%A7%E0%B8%A2%E0%B9%83%E0%B8%99%E0%B8%9B%E0%B8%B5%202552.pdf, Bureau of Health Policy and Strategy, Ministry of Public Health Thailand.
5. Lim SS, Gaziano TA, Gakidou E, Reddy KS, Farzadfar F, Lozano R, Rodgers A. Prevention of cardiovascular disease in high-risk individuals in low-income and middle-income countries: health effects and costs. Lancet 2007, 370:2054-2062. 10.1016/S0140-6736(07)61699-7, 18063025.
6. He FJ, MacGregor GA. Reducing population salt intake worldwide: From evidence to implementation. Prog Cardiovasc Dis 2010, 52:363-382. 10.1016/j.pcad.2009.12.006, 20226955.
7. Campbell N, Correa-Rotter R, Neal B, Cappuccio FP. New evidence relating to the health impact of reducing salt intake. Nutr MetabCardiovasc Dis 2011, 21:617-619.
8. Strazzullo P, D'Elia L, Kandala N-B, Cappuccio FP. Salt intake, stroke, and cardiovascular disease: meta-analysis of prospective studies. BMJ 2009, 339:b4567. 10.1136/bmj.b4567, 2782060, 19934192.
9. Tuomilehto J, Jousilahti P, Rastenyte D, Moltchanov V, Tanskanen A, Pietinen P, Nissinen A. Urinary sodium excretion and cardiovascular mortality in Finland: a prospective study. Lancet 2001, 357:848-851. 10.1016/S0140-6736(00)04199-4, 11265954.
10. Otsuka R, Kato Y, Imai T, Ando F, Shimokata H. Decreased salt intake in Japanese men aged 40 to 70 years and women Aged 70 to 79 years: An 8-year longitudinal study. J Am Diet Assoc 2011, 111:844-850. 10.1016/j.jada.2011.03.020, 21616196.
11. Haruyama Y, Muto T, Nakade M, Kobayashi E, Ishisaki K, Yamasaki A. Fifteen-month lifestyle intervention program to improve cardiovascular risk factors in a community population in Japan. Tohoku J Exper Med 2009, 217:259-269.
12. Ueshima H, Sekikawa A, Miura K, Turin TC, Takashima N, Kita Y, Watanabe M, Kadota A, Okuda N, Kadowaki T, et al. Cardiovascular disease and risk factors in Asia. Circulation 2008, 118:2702-2709. 10.1161/CIRCULATIONAHA.108.790048, 3096564, 19106393.
13. Khonputsa P, Veerman JL, Vathesatogkit P, Vanavanan S, Lim S, Bertram M, Vos T, Ratanachaiwong W, Yamwong S. Blood pressure, cholesterol and cardiovascular disease in Thailand. Heart Asia 2010, 2:42-46.
14. Cobiac LJ, Vos T, Veerman JL. Cost-effectiveness of interventions to reduce dietary salt intake. Heart 2010, 96:1920-1925. 10.1136/hrt.2010.199240, 21041840.
15. Micah L. Biobehavior of the human love of salt. Neurosci Bio Behav Rev 2009, 33:1-17.
16. Ohta Y, Tsuchihashi T, Ueno M, Kajioka T, Onaka U, Tominaga M, Eto K. Relationship between the awareness of salt restriction and the actual salt intake in hypertensive patients. Hypertens Res 2004, 27:243-246. 10.1291/hypres.27.243, 15127881.
17. Acock M, Jackson H. Seeing and acquiring beliefs. Mind 1979, 88:370-383.
18. D'Agostino RB, Vasan RS, Pencina MJ, Wolf PA, Cobain M, Massaro JM, Kannel WB. General cardiovascular risk profile for use in primary care. Circulation 2008, 117:743-753. 10.1161/CIRCULATIONAHA.107.699579, 18212285.
19. Framingham Heart Study General Cardiovascular Disease (10 years Risk): Risk Score Calculators http://www.framinghamheartstudy.org/risk/gencardio.html#, Framingham Heart Study.
20. ISRCTN39416277 Salt reduction intervention: a cluster randomized trial in northern Thailand http://www.controlled-trials.com/ISRCTN39416277, ISRCTN39416277.
21. McRae A, Weijer C, Binik A, Grimshaw J, Boruch R, Brehaut J, Donner A, Eccles M, Saginur R, White A, Taljaard M. When is informed consent required in cluster randomized trials in health research?. Trials 2011, 12:202-214. 10.1186/1745-6215-12-202, 3184061, 21906277.
22. ATAGO Digital salt meter:Digital Hand-held " Pocket" Salt-meter PAL-ES2 http://www.atago.net/english/products_salt.php#03, ATAGO.
23. KME-03 Kouno Me Institute :Salinity Checker http://www.lustertech.jp/Salinitychecker.pdf, KME-03.
24. Bureau of Non-communicable disease MOPH Thailand http://thaincd.com/document/file/download/leaflet/%E0%B8%A5%E0%B8%94%E0%B9%80%E0%B8%84%E0%B9%87%E0%B8%A1_%E0%B8%95%E0%B9%89%E0%B8%B2%E0%B8%99%E0%B9%82%E0%B8%A3%E0%B8%84.pdf, Bureau of Non-communicable disease.
25. Aekplakorn W, Bunnag P, Woodward M, Sritara P, Cheepudomwit S, Yamwong S, Yipintsoi T, Rajatanavin R. A risk score for predicting incident diabetes in the Thai population. Diabet Care 2006, 29:1872-1877.
26. Association AD. Diagnosis and classification of diabetes mellitus. Diabet Care 2010, 33:S62-S69.
27. Thai Hypertension Society Guidelines in the Treatment of Hypertension 2008, http://www.thaihypertension.org/2008guideline.pdf, Thai Hypertension Society.
28. Liu K, Dyer A, Cooper R, Stamler R, Stamler J. Can overnight urine replace 24-hour urine collection to asses salt intake?. Hypertension 1979, 1:529-536. 10.1161/01.HYP.1.5.529, 541044.
29. Luft F, Fineberg N, Sloan R. Overnight urine collections to estimate sodium intake. Hypertension 1982, 4:494-498. 10.1161/01.HYP.4.4.494, 6891373.
30. Brewster L, Bohte E, van Montfrans G. Systematic review of the use of spot and overnight urine for assessment of sodium excretion: 5D.05. J Hypertens 2010, 28:e230.
31. Cook NR, Cutler JA, Obarzanek E, Buring JE, Rexrode KM, Kumanyika SK, Appel LJ, Whelton PK. Long term effects of dietary sodium reduction on cardiovascular disease outcomes: observational follow-up of the trials of hypertension prevention (TOHP). BMJ 2007, 334:885-888. 10.1136/bmj.39147.604896.55, 1857760, 17449506.
32. The Framingham Heart Study General Cardiovascular Disease and calculator http://www.framinghamheartstudy.org/risk/gencardio.html, The Framingham Heart Study.
33. Alderman MH. The Cochrane review of sodium and health. Am J Hypertens 2011, 24:854-856. 10.1038/ajh.2011.117, 21731063.
34. Stolarz-Skrzypek K, Kuznetsova T, Thijs L, Tikhonoff V, Seidlerová J, Richart T, Jin Y, Olszanecka A, Malyutina S, Casiglia E, et al. Fatal and nonfatal outcomes, incidence of hypertension, and blood pressure changes in relation to urinary sodium excretion. JAMA 2011, 305:1777-1785. 10.1001/jama.2011.574, 21540421.
35. Yamasue K, Tochikubo O, Kono E, Maeda H. Self-monitoring of home blood pressure with estimation of daily salt intake using a new electrical device. J Hum Hypertens 2006, 20:593-598. 10.1038/sj.jhh.1002049, 16710288.
36. Asaria P, Chisholm D, Mathers C, Ezzati M, Beaglehole R. Chronic disease prevention: health effects and financial costs of strategies to reduce salt intake and control tobacco use. Lancet 2007, 370:2044-2053. 10.1016/S0140-6736(07)61698-5, 18063027.
37. Dans A, Ng N, Varghese C, Tai ES, Firestone R, Bonita R. The rise of chronic non-communicable diseases in southeast Asia: time for action. Lancet 2011, 377:680-689. 10.1016/S0140-6736(10)61506-1, 21269677.
38. World Health Organization Global Strategy on Diet, Physical Activity and Health:Population sodium reduction strategies http://www.who.int/dietphysicalactivity/reducingsalt/en/index.html, World Health Organization.